reversible covalent modification of one or more amino acid residues in the enzyme. • Over 500 different types of covalent modifications have been found in proteins. Common modifications include phosphorylation, adenylylation, methylation, myristoylation, and ubiquitination. • In the case of ubiquitination, the small protein ubiquitin is attached to a lysine residue in the target protein flagging it for proteolytic destruction. • The modifying groups are usually attached to a regulated enzyme by a separate modifying enzyme (e.g., a methylase in the case of methylation). • Introduction of the modifying group alters the local properties of the enzyme which typically undergoes a change in conformation and activity. • Introduction of a hydrophobic myristoyl group triggers the association of the protein with a membrane. • Phosphorylation is the most important type of covalent modification. Regulation by Reversible Phosphorylation
• It is estimated that one-third of all proteins in a eukaryotic cell are
phosphorylated, and one, or often many phosphorylation events are part of virtually every regulatory process. • Some proteins have only one phosphorylation site, whereas others have several, and a few have dozens of sites for phosphorylation. • The attachment of phosphoryl groups to specific amino acid residues of a protein is catalyzed by enzymes called protein kinases. • In these reactions, typically the -phosphoryl group from a nucleoside triphosphate (usually ATP) is transferred to a particular Ser, Thr, Tyr, or occasionally His residue in the target protein. • Removal of the same phosphoryl group from the protein is performed by enzymes called protein phosphatases. • The introduced phosphoryl group can cause major changes in the conformation of the modified enzyme by virtue of steric effects, or hydrogen bonding and ionic interactions to neighboring residues. • This can lead to effects on substrate binding and catalysis. Regulation by Reversible Phosphorylation: Muscle Glycogen Phosphorylase
• An important example of enzyme regulation by phosphorylation is seen
with glycogen phosphorylase of muscle and liver. • This enzyme catalyzes the breakdown of glycogen stores via the reaction • Glycogen(n) + Pi glycogen(n-1) + glucose 1-P • Glycogen phosphorylase is a homodimeric enzyme that exists in two forms--the less active phosphorylase b form and the more active phosphorylase a species (Fig. 6-36). • Activation by phosphorylation is catalyzed by the enzyme phosphorylase kinase which attaches phosphate groups to serine residues (Ser 14) located near the N-termini of both subunits.
• The enzyme phosphoprotein
phosphatase 1 (PP1) removes these two phosphates by hydrolysis, inactivating the enzyme. • The phosphorylation of Ser14 causes major structural changes near the N- termini of the glycogen phosphorylase chains that produce a more active enzyme. • Note that glycogen phosphorylase is also regulated by noncovalent allosteric modulation Conformational Changes in Allosteric Regulatory Enzymes The modulators of an allosteric enzyme may be inhibitory or stimulatory. If the modulator and substrate are the same the regulation is called homotropic. If the modulator and substrate are different molecules the regulation is called heterotropic. Allosteric enzymes generally have one or more regulatory, or allosteric, sites for binding the modulator. Just as an enzyme’s active site is specific for its substrate, each regulatory site is specific for its modulator. In many allosteric enzymes, the substrate-binding and modulator-binding sites(s) are on different subunits. These are called the catalytic (C) and regulatory (R) subunits.
In Fig. 6-32, binding of the positive
(stimulatory) modulator (M) to its specific site on the regulatory subunit is communicated to the catalytic subunit through a conformational change. This change renders the catalytic subunit active and capable of binding the substrate (S) with higher affinity. On dissociation of the modulator from the regulatory subunit, the enzyme reverts to its inactive or less active form Feedback Inhibition • When a metabolic pathway is switched off by its end-product. • End-product usually inhibits an enzyme earlier in the pathway. • Prevents the cell from wasting chemical resources